BQPrime
•68% Informative
The prospect of the U.S. generics market has experienced a revival in the recent past.
This has been driven by price stability in the base portfolio and lesser competition due to financial and/or regulatory constraints of some companies.
Cipla ’s robust abbreviated new drug application pipeline with.
complex products (inhalers, peptides, injectable, etc.) should drive consistent growth in the US generics segment.
VR Score
74
Informative language
81
Neutral language
63
Article tone
formal
Language
English
Language complexity
56
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links